SEC 13F Intelligence

Nwi Management LP / XLRN

Nwi Management LP’s Acceleron Pharma Inc Position

Does Nwi Management LP own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 200.0K shares worth $34M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$34M
Q3 2021
Shares
200.0K
% of Portfolio
+2.13%
Quarters Held
5
position exited

Position History XLRN

Reported value by quarter
Q3 ’20: $23MQ3 ’20Q4 ’20: $26MQ4 ’20Q1 ’21: $27MQ1 ’21Q2 ’21: $25MQ2 ’21Q3 ’21: $34MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021200.0K$34M+2.13%
Q2 2021200.0K$25M+1.54%
Q1 2021200.0K$27M+2.26%
Q4 2020200.0K$26M+2.54%
Q3 2020200.0K$23M+1.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nwi Management LP’s full portfolio or all institutional holders of XLRN.